Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hypersensitivity angiitis, Henoch-Schönlein purpura]

Y Tomino1

  • 1Department of Medicine, Juntendo University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1994
PubMed
Summary

Hypersensitivity angiitis and Henoch-Schönlein purpura, both forms of leukocytoclastic vasculitis, share effective treatments. Intensive plasma exchange, steroids, and cyclophosphamide benefit patients with these conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient classification and outcome prediction in IgA nephropathy.

Computers in biology and medicine·2015
Same author

Targeted IgA Fc receptor I (FcαRI) therapy in the early intervention and treatment of pristane-induced lupus nephritis in mice.

Clinical and experimental immunology·2015
Same author

Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin.

Diabetologia·2012
Same author

Asymmetric dimethylarginine: a novel cardiovascular risk factor in end-stage renal disease.

The Journal of international medical research·2012
Same author

Negative regulation of inflammatory responses by immunoglobulin A receptor (FcαRI) inhibits the development of Toll-like receptor-9 signalling-accelerated glomerulonephritis.

Clinical and experimental immunology·2011
Same author

Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis.

Lupus·2011

Area of Science:

  • Immunology
  • Rheumatology
  • Nephrology

Background:

  • Hypersensitivity angiitis and Henoch-Schönlein purpura are distinct vasculitides.
  • Both are classified under leukocytoclastic vasculitis.
  • Hypersensitivity angiitis is linked to drug/infection triggers and affects small vessels, often with ANCA positivity.
  • Henoch-Schönlein purpura involves multiple organs and shows IgA deposition in the kidneys.

Purpose of the Study:

  • To summarize the pathogenesis and treatment of hypersensitivity angiitis and Henoch-Schönlein purpura.
  • To highlight the classification of these conditions within leukocytoclastic vasculitis.
  • To review effective therapeutic strategies for both diseases.

Main Methods:

  • Literature review and synthesis of existing data on hypersensitivity angiitis and Henoch-Schönlein purpura.
  • Analysis of pathogenic mechanisms, clinical manifestations, and diagnostic markers.
  • Evaluation of treatment outcomes for combined therapeutic approaches.

Main Results:

  • Hypersensitivity angiitis often involves venules/capillaries and is associated with drug/infectious triggers and myeloperoxidase-ANCA.
  • Henoch-Schönlein purpura presents with systemic vasculitis, notably IgA nephropathy characterized by IgA1 and C3 deposition.
  • Combined therapy with plasma exchange, steroids, and cyclophosphamide demonstrated efficacy in managing both conditions.

Conclusions:

  • Hypersensitivity angiitis and Henoch-Schönlein purpura, despite differing features, fall under leukocytoclastic vasculitis.
  • Understanding their distinct pathogenic pathways and diagnostic markers is crucial.
  • Intensive treatment regimens combining plasma exchange, steroids, and cyclophosphamide offer a promising therapeutic avenue for both vasculitides.

Related Experiment Videos